CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (NASDAQ: GENZ) announced today that it has begun shipping vials of newly produced Cerezyme® (imiglucerase for injection) manufactured at its Allston Landing plant. The company also provided an update on its progress to restore supplies of Cerezyme and Fabrazyme® (agalsidase beta) for patients worldwide.
